NEW YORK (GenomeWeb News) – Genetix today announced that it has acquired analysis and data management software firm SlidePath for undisclosed consideration.

Genetix said that the acquisition will complement its offerings in the digital pathology market. Specifically, the Hampshire, UK-based firm said that SlidePath's products will complement its Ariol platform, which is a digital imaging and analysis solution for quantifying biomarkers in tissue sections and tissue microarrays.

SlidePath will continue to operate from its headquarters in Dublin, Ireland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.